Cancer Epidemiology Biomarkers & Prevention
译名:癌症流行病学、生物标志物与预防
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
3-5
2026
影响因子区间
—
平台估算
2%
2025
中国作者发文占比
£3490.00 GBP / $5090.00 USD / €3990.00 EUR.
收费
期刊简介:Cancer Epidemiology, Biomarkers & Prevention publishes original peer-reviewed, population-based research on cancer etiology, prevention, surveillance, and survivorship. The following topics are of special interest: descriptive, analytical, and molecular epidemiology; biomarkers including assay development, validation, and application; chemoprevention and other types of prevention research in the context of descriptive and observational studies; the role of behavioral factors in cancer etiology and prevention; survivorship studies; risk factors; implementation science and cancer care delivery; and the science of cancer health disparities. Besides welcoming manuscripts that address individual subjects in any of the relevant disciplines, CEBP editors encourage the submission of manuscripts with a transdisciplinary approach.
【译文】癌症流行病学、生物标志物与预防发表基于人群的原创同行评审研究,涉及癌症病因、预防、监测和生存。以下主题特别受关注:描述性、分析性和分子流行病学;包括检测方法开发、验证和应用在内的生物标志物;在描述性和观察性研究背景下进行的化学预防和其他预防研究;行为因素在癌症病因和预防中的作用;生存研究;风险因素;实施科学和癌症护理提供;以及癌症健康差异的科学。除了欢迎针对相关学科中任何个别主题的稿件外,CEBP编辑还鼓励提交跨学科方法的稿件。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |